z-logo
Premium
Fluorescein angiography based classification of retinopathy of prematurity
Author(s) -
SUZANI M,
TRAVERSA E,
BARILLà D,
GUAGLIANO R,
BERTONE C,
ANSELMETTI G,
BIANCHI PE
Publication year - 2011
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2011.371.x
Subject(s) - retinopathy of prematurity , medicine , posterior pole , gestational age , fundus (uterus) , fluorescein angiography , ophthalmology , angiography , shunt (medical) , retinopathy , birth weight , surgery , retinal , pediatrics , pregnancy , diabetes mellitus , genetics , endocrinology , biology
Purpose To select fluorescein angiography (FA) signs detected in Retinopathy of prematurity (ROP) in order to propose a new classification. Methods From December 2009 to December 2010, 15 patients affected by ROP (stage 2 or 3, zone 2, no plus) were evaluated at San Matteo Hospital(Pavia) and Maria Vittoria Hospital (Torino) along with their FA exams by an expert in paediatric retina diseases. Among the multiple FA features in ROP, we considered: ischaemic area posterior to the shunt, leakage at the vascularised/avascularised junction (v/av j) and peripheral plus (vessel tortuosity just beyond the v/av). Results Patient group characteristics were: Mean Gestational age: 25 weeks Mean Weight at Birth: 657 g Mean Age at ROP diagnosis: 30 weeks Considering the described criteria, we were able to detected a new class of ROP patients; they were all described as type 2 ROP on the basis of fundus examinations, while FA characteristics permitted to: ‐ Identify a more aggressive subtype of ROP type 2, in need of a sudden treatment ‐ Plan FA based laser administration which involved the ischaemic area near the shunt All the patients in the study received a laser treatment with favourable structural and visual outcome. Conclusion FA classification allows to advance and/or improve laser administration in FA selected patients with retinopathy of prematurity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here